# IQIRVO
> **NDA218860** · New Drug Application · Sponsor: IPSEN · Approved 2024-06-10
## Drug
- **FDA Application Number:** NDA218860
- **Application type:** New Drug Application
- **Brand name:** IQIRVO
- **Generic name:** ELAFIBRANOR
- **Active ingredients:** ELAFIBRANOR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IPSEN
- **Manufacturer:** Ipsen Biopharmaceuticals, Inc.
- **First approval:** 2024-06-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218860)
---
*AI Analytics · CC0 1.0*